Evidence map›Paper›PMID 24088503›Full record

ArticleBMC cancer2013

HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis.

Thais Chile, Maria Angela Henriques Zanella Fortes, Maria Lúcia Cardillo Corrêa-Giannella, Helena Paula Brentani, Durvanei Augusto Maria, Renato David Puga, Vanessa de Jesus R de Paula, Marcia Saldanha Kubrusly, Estela Maria Novak, Telésforo Bacchella and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Differential and Prognostic Significance of HOXB7 in Gliomas.Frontiers in cell and developmental biology · 2021
    Article
  4. Article
  5. Review
  6. Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types.Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Thais ChileLaboratory for Cellular and Molecular Endocrinology (LIM-25), University of São Paulo Medical School, Av, Dr, Arnaldo, 455 # 4305, São Paulo, SP, 01246-903, Brazil. rrgiorgi2@hotmail.com.
Maria Angela Henriques Zanella Fortes
Maria Lúcia Cardillo Corrêa-Giannella
Helena Paula Brentani
Durvanei Augusto Maria
Renato David Puga
Vanessa de Jesus R de Paula
Marcia Saldanha Kubrusly
Estela Maria Novak
Telésforo Bacchella
Ricardo Rodrigues Giorgi
Universidade de São Paulo · BRAC Camargo Hospital · BRInstituto Butantan · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman homeobox genes encode nuclear proteins that act as transcription factors involved in the control of differentiation and proliferation. Currently, the role of these genes in development and tumor progression has been extensively studied. Recently, increased expression of HOXB7 homeobox gene (HOXB7) in pancreatic ductal adenocarcinomas (PDAC) was shown to correlate with an invasive phenotype, lymph node metastasis and worse survival outcomes, but no influence on cell proliferation or viability was detected. In the present study, the effects arising from the knockdown of HOXB7 in PDAC cell lines was investigated.

methodsReal time quantitative PCR (qRT-PCR) (Taqman) was employed to assess HOXB7 mRNA expression in 29 PDAC, 6 metastatic tissues, 24 peritumoral tissues and two PDAC cell lines. siRNA was used to knockdown HOXB7 mRNA in the cell lines and its consequences on apoptosis rate and cell proliferation were measured by flow cytometry and MTT assay respectively.

resultsOverexpression of HOXB7 mRNA was observed in the tumoral tissues and in the cell lines MIA PaCa-2 and Capan-1. HOXB7 knockdown elicited (1) an increase in the expression of the pro-apoptotic proteins BAX and BAD in both cell lines; (2) a decrease in the expression of the anti-apoptotic protein BCL-2 and in cyclin D1 and an increase in the number of apoptotic cells in the MIA PaCa-2 cell line; (3) accumulation of cell in sub-G1 phase in both cell lines; (4) the modulation of several biological processes, especially in MIA PaCa-2, such as proteasomal ubiquitin-dependent catabolic process and cell cycle.

conclusionThe present study confirms the overexpression of HOXB7 mRNA expression in PDAC and demonstrates that decreasing its protein level by siRNA could significantly increase apoptosis and modulate several biological processes. HOXB7 might be a promising target for future therapies.

Indexed as

Gene Expression Regulation, NeoplasticRNA, MessengerApoptosisCarcinoma, Pancreatic DuctalCell Cycle CheckpointsCell Line, TumorCell ProliferationE2F Transcription FactorsGene DosageGene Expression ProfilingGene Knockdown TechniquesGene SilencingHomeodomain ProteinsHumansPancreatic NeoplasmsReproducibility of ResultsE2F Transcription FactorsHomeodomain ProteinsHOXB7 protein, humanRetinoblastoma ProteinRNA, MessengerRNA, Small Interfering

Identifiers

PMID24088503
PMCPMC3851693
OpenAlexW1992359373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.